Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs directed at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where therapy choices remain limited. Make use of the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Check out https://financefeeds.com/bitwise-launches-dual-bitcoin-and-ethereum-etf-after-sec-greenlight/